TW

Taiwan

12571 clinical trials

Find Trials

Clinical Trials (12571)

Showing 20 of 12,571 trialsScroll for more
NCT07227402Phase 34 sites

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Recruiting
NCT06430801Phase 33 sites

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT06966700Phase 35 sites

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Recruiting
NCT07181109Phase 38 sites

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Recruiting
NCT06422143Phase 38 sites

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Recruiting
NCT06441435Not Applicable2 sites

The Effect of AC-134 in Chronic Kidney Diseases

Completed
NCT05801029Phase 27 sites

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

Active Not Recruiting
NCT07218029Phase 32 sites

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Recruiting
NCT06170788Phase 311 sites

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Recruiting
NCT05979441Phase 32 sites

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Enrolling By Invitation
NCT07190248Phase 36 sites

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Recruiting
NCT06401044Phase 12 sites

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Recruiting
NCT06657144Phase 110 sites

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Recruiting
NCT07062510Not Applicable1 site

The Effects of Balanced Seating Pressure on Pelvic Asymmetry: A Pilot Study

Completed
NCT06532292Not Applicable1 site

Physical Therapy Intervention for Pelvic Organ Prolapses

Completed
NCT03486873Phase 312 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06159673Phase 25 sites

ACP-204 in Adults With Alzheimer's Disease Psychosis

Recruiting
NCT06780111Phase 17 sites

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Recruiting
NCT06136559Phase 34 sites

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Recruiting
NCT06935110Not Applicable2 sites

Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch

Recruiting